
Active Pharmaceutical Ingredients
- Lidocaine Base USP/BP/EP
- Lidocaine HCl USP/BP/EP/IP
- Lidocaine Hydrochloride USP/BP/EP/IP
(Micronised)
- Bisacodyl USP/BP/EP
- Sodium Picosulphate BP/EP
- Furosemide USP
- Glimepride USP
Active Pharmaceutical Ingredients |
Sr. No. |
Current Product |
Therapeutic uses |
1. |
Lidocaine Base |
Local Anesthetic |
2. |
Lidocaine Hydrochloride |
Local Anesthetic |
3. |
Micronised Lidocaine Hydrochloride |
Local Anesthetic |
Active Pharmaceutical Ingredients
Ready for commercialization |
Sr. No. |
Product list |
Therapeutic uses |
1. |
Bisacodyl
Micronised material available on request |
Stimulant Laxative |
2. |
Sodium Picosulphate |
laxative |
3. |
Furosemide |
Diuretic |
4. |
Glimepride |
an anti-diabetic drug (sulfonylurea-type) |
Active Pharmaceutical Ingredients
Under Development |
Sr. No. |
Product list |
Therapeutic uses |
1. |
Banzocaine |
Local Anesthetic |
2. |
Procaine |
Local Anesthetic |
3. |
Mepivacaine |
Local Anesthetic |
Specifications
Name of the Product |
Lidocaine Hydrochloride |
Molecular Structure |

|
Systematic IUPAC Name |
2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride |
Identifiers |
CAS Number |
6108-05-0 |
Pharmacopoeia |
USP/BP/EP/IP |
Chemical Data |
Formula |
C14H22N2O,HCl,H2O |
Molecular Mass |
288.8 g/mol |
Physical Data |
Melting Point |
74 °C to 79 °C |
Color |
White to yellowish. |
Odor |
Characteristic |
Drug Type |
Approved Drug |
Drug Category |
- Antiarrhythmic Agents
- Anesthetics
|
Dosage Forms |
- Cream
- Gel
- Implant
- Jelly
- Kit
|
- Liquid
- Ointment
- Solution
- Spray
- Injectibles
|
Storage |
Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 40°C (104°F).
(preferably store at temperature between 15 C and 30 C) |
Name of the Product |
Lidocaine Base |
Molecular Structure |

|
Systematic IUPAC Name |
2-(diethylamino)- N-(2,6-dimethylphenyl)acetamide |
Identifiers |
CAS Number |
137-58-6 |
Pharmacopoeia |
USP/BP/EP |
Chemical Data |
Formula |
C14H22N2O |
Molecular Mass |
234.34 g/mol |
Physical Data |
Physical state and appearance |
Solid (Crystalline solid) |
Color |
White to yellowish |
Odor |
Characteristic |
Melting Point |
66oC to 70oC |
Drug Type |
Approved Drug |
Drug Category |
- Antiarrhythmic Agents
- Anesthetics
|
Dosage Forms |
- Cream
- Gel
- Implant
- Jelly
- Kit
|
- Liquid
- Ointment
- Solution
- Spray
|
Storage |
Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 40°C (104°F).
(preferably store at temperature between 15 C and 30 C) |
Name of the Product |
Bisacodyl |
Molecular Structure |

|
Systematic IUPAC Name |
[4-[(4-acetyloxyphenyl)-pyridin-2-yl-methyl]phenyl] acetate |
Identifiers |
CAS Number |
603-50-9 |
Pharmacopoeia |
USP/BP/EP |
Chemical Data |
Formula |
C22H19NO4 |
Molecular Mass |
361.4 g/mol |
Physical Data |
Physical state and appearance |
Solid (Crystalline solid) |
Color |
White to almost white |
Odor |
Characteristic |
Melting Point |
131 °C to 135 °C |
Drug Type |
Approved Drug |
Drug Category |
- Stimulant laxative
|
Dosage Forms |
- Solution
- Tablet
|
Storage |
Store protected from light. Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 40°C (104°F). (preferably store at temperature between 15 C and 30 C) |
Name of the Product |
Sodium Picosulphate |
Molecular Structure |

|
Systematic IUPAC Name |
Disodium 2-[bis(4-sulfonatooxyphenyl)methyl]pyridine |
Identifiers |
CAS Number |
10040-45 |
Pharmacopoeia |
BP/EP |
Chemical Data |
Formula |
C18H13NNa2O8S2,H2O |
Molecular Mass |
499.4 g/mol |
Physical Data |
Physical state and appearance |
Solid (Crystalline solid) |
Color |
White crystalline powder |
Odor |
Characteristic |
Water Content |
3.0% to 5.0% |
Drug Type |
Approved Drug |
Drug Category |
laxative |
Dosage Forms |
- Solution
- Powder
|
Storage |
Store protected from light. Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 40°C (104°F). (preferably store at temperature between 15 C and 30 C) |
|
 |
|